Kimberly A. McDowell
University of Wisconsin–Madison
ORCID: 0009-0000-5412-105XAlso affiliated with UW Health University Hospital, University of Wisconsin Carbone Cancer Center, Nanotherapeutics (United States), University of Wisconsin American Family Children's Hospital, Capsida Biotherapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra N. Kaplan, Julie R. Park +4 more
Papers
Driven by 3 papers — median percentile 51. Top paper: “A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors”.
Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra N. Kaplan, Julie R. Park +4 more
Zachary S. Morris, Jacquelyn A. Hank, Erik A. Ranheim, Cindy Zuleger, Kimberly A. McDowell +13 more
Kirsti L. Walker, Matthew H. Forsberg, Kimberly A. McDowell, Myriam N. Bouchlaka, Diana Drier +4 more